Source : Biocon Limited Tuesday, December 27, 2016 12:52PM IST (7:22AM GMT)   (BSE:532523)(NSE:BIOCON) Journal of the American Medical Association (JAMA) Publishes Mylan and Biocon’s Proposed Biosimilar Trastuzumab Phase 3 Data   Bengaluru,...

More